Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$276M |
| 2 |
IBM
IBM
|
+$272M |
| 3 |
Procter & Gamble
PG
|
+$161M |
| 4 |
Colgate-Palmolive
CL
|
+$151M |
| 5 |
BBBY
Bed Bath & Beyond Inc
BBBY
|
+$146M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$405M |
| 2 |
CELG
Celgene Corp
CELG
|
+$207M |
| 3 |
Booking.com
BKNG
|
+$123M |
| 4 |
Eli Lilly
LLY
|
+$114M |
| 5 |
BEAM
BEAM INC COM STK (DE)
BEAM
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.85% |
| 2 | Healthcare | 13.92% |
| 3 | Consumer Discretionary | 12.37% |
| 4 | Industrials | 10.61% |
| 5 | Consumer Staples | 9.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
DMC Global
BOOM
$153M
| $1.83M | ﹤0.01% |
82,500
-4,679
| -5% | -$96.5K |
|
|
DVAX
1777
DELISTED
Dynavax Technologies
DVAX
| $1.82M | ﹤0.01% |
+113,929
| New | +$1.72M |
|
|
MCEP
1778
DELISTED
Mid-Con Energy Partners, LP
MCEP
| $1.82M | ﹤0.01% |
3,923
+1,581
| +68% | +$702K |
|
1779
First Busey Corp
BUSE
$2.57B
| $1.82M | ﹤0.01% |
104,284
+24,777
| +31% | +$420K |
|
|
AXAS
1780
DELISTED
Abraxas Petroleum Corp
AXAS
| $1.82M | ﹤0.01% |
14,506
+9,127
| +170% | +$931K |
|
|
DFRG
1781
DELISTED
Del Frisco's Restaurant Group, Inc. Common Stock
DFRG
| $1.81M | ﹤0.01% |
65,686
+53,286
| +430% | +$1.42M |
|
|
CKP
1782
DELISTED
CHECKPOINT SYSTEMS INC
CKP
| $1.81M | ﹤0.01% |
129,400
-29,911
| -19% | -$391K |
|
|
PBIP
1783
DELISTED
Prudential Bancorp, Inc.
PBIP
| $1.81M | ﹤0.01% |
157,153
+29,267
| +23% | +$319K |
|
|
BSTC
1784
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $1.81M | ﹤0.01% |
67,009
+52,109
| +350% | +$1.36M |
|
1785
8x8 Inc
EGHT
$296M
| $1.8M | ﹤0.01% |
223,230
+168,730
| +310% | +$1.48M |
|
1786
Ethan Allen Interiors
ETD
$579M
| $1.8M | ﹤0.01% |
72,900
-119,700
| -62% | -$2.93M |
|
|
AKS
1787
DELISTED
AK Steel Holding Corp
AKS
| $1.8M | ﹤0.01% |
+225,634
| New | +$1.56M |
|
|
DNB
1788
DELISTED
Dun & Bradstreet
DNB
| $1.8M | ﹤0.01% |
16,300
-198,600
| -92% | -$20.8M |
|
|
AFFX
1789
DELISTED
Affymetrix Inc
AFFX
| $1.77M | ﹤0.01% |
198,280
-570,943
| -74% | -$4.54M |
|
|
XCO
1790
DELISTED
Exco Resources
XCO
| $1.76M | ﹤0.01% |
19,980
-46,957
| -70% | -$3.99M |
|
|
HNH
1791
DELISTED
Handy & Harman Holdings Ltd.
HNH
| $1.76M | ﹤0.01% |
65,800
-5,900
| -8% | -$135K |
|
1792
Monarch Casino & Resort
MCRI
$2.23B
| $1.76M | ﹤0.01% |
116,200
+2,600
| +2% | +$42.1K |
|
1793
Green Brick Partners
GRBK
$3.03B
| $1.75M | ﹤0.01% |
389,200
+337,959
| +660% | +$1.42M |
|
1794
Daktronics
DAKT
$977M
| $1.74M | ﹤0.01% |
146,248
+35,848
| +32% | +$465K |
|
|
PMT
1795
PennyMac Mortgage Investment
PMT
$826M
| $1.74M | ﹤0.01% |
79,400
-338,400
| -81% | -$7.53M |
|
1796
Horace Mann Educators
HMN
$2.13B
| $1.74M | ﹤0.01% |
55,600
-4,563
| -8% | -$135K |
|
1797
Pediatrix Medical
MD
$2.16B
| $1.73M | ﹤0.01% |
29,700
+24,700
| +494% | +$1.45M |
|
|
LHCG
1798
DELISTED
LHC Group LLC
LHCG
| $1.73M | ﹤0.01% |
80,813
+17,703
| +28% | +$369K |
|
|
MILL
1799
DELISTED
MILLER ENERGY RESOURCES, INC COM STK
MILL
| $1.73M | ﹤0.01% |
+269,700
| New | +$1.39M |
|
|
MANT
1800
DELISTED
Mantech International Corp
MANT
| $1.72M | ﹤0.01% |
58,400
-56,401
| -49% | -$1.66M |
|
Similar funds
Jim Simons's Q2 2014 Portfolio in Review
As of Q2 2014, Jim Simons held 3,246 positions worth $42.9B, up 2.9% from $41.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons's Q2 2014 filing shows 450 new, 1,273 increased, 1,008 reduced and 492 closed positions. Its largest new stake was Procter & Gamble: 2,001,729 shares worth $157M. The largest sale was Verizon, an estimated $405M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q2 2014 buy was Procter & Gamble: 2,001,729 shares worth $157M.
- Jim Simons added most to Pfizer in Q2 2014, an estimated $276M increase.
- Jim Simons's biggest Q2 2014 reduction was Verizon, cutting an estimated $405M.
- Jim Simons fully exited Booking.com in Q2 2014, selling an estimated $123M.
- Jim Simons's ten largest holdings make up 14% of its $42.9B portfolio in Q2 2014.
- Jim Simons opened 450 new positions and closed 492 in Q2 2014.
- Jim Simons's portfolio value rose 2.9% quarter-over-quarter to $42.9B.
Based on Renaissance Technologies's 13F filing for Q2 2014, filed 13 Aug 2014.